At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 64 enrolled
Drug / intervention
Telmisartan 80 mg and amlodipine 5 mg +1 moredrug
Likely dose
Telmisartan 80 mg and amlodipine 5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Upstream-therapy by Telmisartan and Amlodipine Combination for Improvement of Left Atrial Mechanical Function After Pulmonary Vein Antrum Isolation
Research Institute for Complex Problems of Cardiovascular Diseases, Russia·interventional·Posted Apr 12, 2016·Updated Mar 22, 2017
In Brief
A Phase 4 clinical trial evaluating Telmisartan 80 mg and amlodipine 5 mg and Placebo (for telmisartan and amlodipine) for Atrial Fibrillation. Completed, enrolled 64 participants.
Detailed Summary
The objective of the study was to estimate the efficacy of telmisartan and amlodipine combination on the restoration of left atrial mechanical function after atrial fibrillation catheter ablation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
Primary CompletionJan 2016
Study CompletionFeb 2016
First PostedApr 2016
TodayJul 2026
First PostedApr 12, 2016
Enrollment StartNov 1, 2015
Primary CompletionJan 1, 2016
Study CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.2 years ago
Interventions
Telmisartan 80 mg and amlodipine 5 mgdrug
Placebo (for telmisartan and amlodipine)drug
Sugar pill manufactured to mimic telmisartan 80 mg and amlodipine 5 mg tablet